Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.
Hassan A HamaliMuhammad SaboorGasim DobieAymen M MadkhaliMohammad S AkhterAli HakamyHesham M Al-MekhlafiDenise E JacksonYahya H MatariAbdullah A MobarkiPublished in: Infection and drug resistance (2022)
Elevated levels of procoagulant MVs and TF-bearing MVs in patients with COVID-19 are suggested to be (i) early potential markers to predict the severity of COVID-19 (ii) a novel circulatory biomarker to evaluate the procoagulant activity and severity of COVID-19.